As a HER2 IHC scoring system has not been established for cancers other than breast and gastric cancers, we sought to evaluate HER2 protein expression by IHC in solid cancers using the breast cancer scoring system, and in luminal cancers using the gastric cancer scoring system. Here, ERBB2 is linked to breast cancer.